Ongoing Coverage:

Michigan Voices

Sarah Alvarez
Sarah Alvarez
Public Insight Journalist
John U. Bacon
John U. Bacon
Essay/Analysis: Sports Commentator
Mark Brush
Mark Brush
Reporter/Producer
Cynthia Canty
Cynthia Canty
Host, Stateside with Cynthia Canty
Steve Carmody
Steve Carmody
Mid Michigan Reporter/Producer
Zoe Clark
Zoe Clark
Reporter/Producer
Sarah Cwiek
Sarah Cwiek
Sarah Cwiek - Detroit Reporter/Producer
Vincent Duffy
Vincent Duffy
News Director
Dustin Dwyer
Dustin Dwyer
Reporter/Producer
Emily Fox
Emily Fox
Morning Edition Producer
Lester Graham
Lester Graham
Investigative Reporter
Jennifer Guerra
Jennifer Guerra
Reporter/Producer
Sarah Hulett
Sarah Hulett
Assistant News Director
Jack Lessenberry
Jack Lessenberry
Essay/Analysis: Political Commentator
Mercedes Mejia
Mercedes Mejia
Reporter/Producer
Rina Miller
Rina Miller
Reporter/Producer
Jake Neher
Jake Neher
MPRN Capitol Reporter
Kyle Norris
Kyle Norris
Reporter/Producer
Mike Perini
Mike Perini
Host - Middays
Rick Pluta
Rick Pluta
Reporter / Producer - Michigan Public Radio Network
Tracy Samilton
Tracy Samilton
Auto Reporter/Producer
Christina Shockley
Christina Shockley
Host - Morning Edition
Lindsey Smith
Lindsey Smith
West Michigan Reporter/Producer
Kate Wells
Kate Wells
Arts & Culture Reporter/Producer
Jennifer White
Jennifer White
Host - All Things Considered
Rebecca Williams
Rebecca Williams
Reporter/Producer - The Environment Report

Tagged: Sid Gilman

Health
2:07 pm
Wed November 21, 2012

Money, ego, and meds: Why would UM doc sell out to hedge fund?

Credit University of Michigan Health Systems
Dr. Sid Gilman of the University of Michigan
Share
E-mail
Comments
By

You're an 80-year-old famed neurologist at the University of Michigan. You're a giant in your field, with a list of honors and awards as long as your arm. You're such a big name in Alzheimer's research that major drug companies ask you to run their clinical trials.

And then you blow it all by giving secret information to a hedge fund investor in what the FBI and the SEC are calling most lucrative insider trading scheme ever. 

But, why?

The Money

Read more